Target-based Classification of Drugs

[ Brite menu | Download htext ]
    

1st Level  2nd Level  3rd Level  4th Level  5th Level  6th Level 

     Remark
 G Protein-coupled receptors
 
 Cytokine receptors
 
 Nuclear receptors
 
 Ion channels
   Cys-loop superfamily
   Glutamate-gated cation channels
   Epithelial and related channels
   Ryanodine and IP3 receptors
   Voltage-gated cation channels
     Na+ channel, SCN alpha, NaV1.x
     Ca2+ channel, CACN alpha-1, CaVx.x
       calcium channel N type [HSA:774] [KO:K04849]
       calcium channel L type [HSA:775 776 778 779] [KO:K04850 K04851 K04853 K04857]
       calcium channel T type [HSA:8911 8912 8913] [KO:K04856 K04855 K04854]
         Mibefradil [DG:DG00328]
           D08217  Mibefradil (INN)
           D05024  Mibefradil dihydrochloride (USAN)
Blocker
Blocker
         Valproic acid [DG:DG00849]
         Flunarizine [DG:DG01006]
         Efonidipine [DG:DG01382]
         Aranidipine
         Ethosuximide
         Penfluridol
         Zonisamide
       voltage-gated Ca2+ channel T type alpha-1I [HSA:8911] [KO:K04856]
       voltage-dependent calcium channel [HSA:781 9254 55799 93589] [KO:K04858 K04859 K04860 K04861]
       calcium channel
     K+ channel, KCNA, Kv1.x (Shaker)
     K+ channel, KCNC, Kv3.x (Shaw)
     K+ channel, KCND, Kv4.x (Shal)
     K+ channel, KCNQ, Kv7.x (KQT-like)
     K+ channel, KCNH, Kv10-12.x (Ether-a-go-go)
     K+ channel, KCNK, K2px.x
   Related to voltage-gated cation channels
   Chloride channels
 
 Transporters
 
 Enzymes
 
 Protein kinases
 
 Cytokines
 
 Others

[ DRUG | BRITE | KEGG2 | KEGG ]
Last updated: November 7, 2014

» Japanese version